Ads
related to: monoclonal antibodies
Search results
Invivyd appoints new Chief Commercial Officer ahead of PEMGARDA launch By Investing.com
Investing.com· 6 days agoLee as its new Chief Commercial Officer. Lee's extensive experience in the pharmaceutical industry...
The Push to Get More People Into Long COVID Studies
Medscape· 3 days agoWhen Ezra Spier was diagnosed with long COVID in late 2022, his main symptom, postexertional malaise, caused fatigue so severe that it forced him to quit...
Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myeloma
MedPage Today· 3 days agoTwo trials show positive outcomes
Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of...
KOIN News 6 Portland· 4 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of...
Morningstar· 4 days agoGilead and Arcus Announce EtrumadenantPlus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer – In Cohort B of the ARC-9 mCRC Study, Etrumadenant ...
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC NEWS· 4 days agoThe chemotherapy-antibody combinations, known as antibody drug conjugates, have been described as...
S2 Episode 3: How Do You Treat Refractory Colorectal Cancer?
Medscape· 2 days agoFor more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify,...
CSPC Pharma Weighs Up Diet Drug For Bigger Bottom Line - CSPC Pharma Gr (OTC:CSPCY), Novo Nordisk...
Benzinga· 1 day agoIt can already fill pharmacy shelves with a wide range of approved drugs for the treatment of...
Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA
Morningstar· 5 days agoSummit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) announced that the Journal of the American Medical Association (JAMA) published a manuscript titled, “Ivonescimab Plus ...
Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in...
Char-Koosta News· 5 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
